-
1
Toripalimab plus chemotherapy in American patients with recurrent or metastatic nasopharyngeal carcinoma: A cost‐effectiveness analysis
Published 2024-05-01Subjects: Get full text
Article -
2
Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer
Published 2021-01-01Subjects: Get full text
Article -
3
-
4
-
5
Toripalimab-Induced Dermatomyositis in a Patient with Metastatic Melanoma
Published 2020-05-01Subjects: Get full text
Article -
6
Toripalimab plus chemotherapy vs. chemotherapy in patients with advanced non-small-cell lung cancer: A cost-effectiveness analysis
Published 2023-02-01Subjects: “…toripalimab…”
Get full text
Article -
7
Hepatic arterial infusion chemotherapy combined with toripalimab and surufatinib for the treatment of advanced intrahepatic cholangiocarcinoma
Published 2025-03-01Subjects: Get full text
Article -
8
Epithelioid hemangioendothelioma of the retroperitoneal giant type treated with Toripalimab: A case report
Published 2023-03-01Subjects: Get full text
Article -
9
-
10
The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study
Published 2021-12-01Subjects: “…toripalimab…”
Get full text
Article -
11
-
12
Effectiveness and Safety of Toripalimab Combination Therapies for Patients With Chemo-Resistant Choriocarcinoma
Published 2022-04-01Subjects: Get full text
Article -
13
Chemo-Immunotherapy Regimes for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis
Published 2022-05-01Subjects: Get full text
Article -
14
Primary pure large cell neuroendocrine carcinoma of the urinary bladder: a case report and literature review
Published 2024-03-01Subjects: Get full text
Article -
15
-
16
Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis
Published 2021-09-01Subjects: Get full text
Article -
17
A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors
Published 2020-08-01Subjects: Get full text
Article -
18
Case Report: Toripalimab: a novel immune checkpoint inhibitor in advanced nasopharyngeal carcinoma and severe immune-related colitis
Published 2023-11-01Subjects: “…Toripalimab…”
Get full text
Article -
19
Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial
Published 2023-10-01Subjects: Get full text
Article -
20
Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report
Published 2025-01-01Subjects: Get full text
Article